Invention Grant
- Patent Title: Imaging methods using 18F-radiolabeled biologics
-
Application No.: US17984825Application Date: 2022-11-10
-
Publication No.: US11806409B2Publication Date: 2023-11-07
- Inventor: David Donnelly , David K. Leung
- Applicant: Bristol-Myers Squibb Company
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Jane E. Remillard, Esq.; Cynthia L. Kanik
- Main IPC: A61K51/08
- IPC: A61K51/08 ; A61K49/00 ; C07K16/28
Abstract:
The invention relates to water soluble 18F-prosthetic groups and the synthesis and use of 18F-labeled biological molecules containing the 18F-prosthetic groups for imaging various processes within the body, for detecting the location of molecules associated with disease pathology, and for monitoring disease progression are disclosed.
Public/Granted literature
- US20230241258A1 IMAGING METHODS USING 18F-RADIOLABELED BIOLOGICS Public/Granted day:2023-08-03
Information query
